QIAGEN NV (QGEN)
QIAGEN Market Cap : 8.380B for April 10, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| InflaRx NV | 73.02M |
| CDT Equity, Inc. | 18.89M |
| LENZ Therapeutics, Inc. | 282.82M |
| Liminatus Pharma, Inc. | 8.567M |
| Oruka Therapeutics, Inc. | 2.959B |
Market Cap Related Metrics
| PE Ratio | 19.78 |
| PS Ratio | 4.022 |
| PEG Ratio | 0.0472 |
| Price to Book Value | 2.204 |
| Price to Free Cash Flow | 18.80 |
| Price | 40.68 |
| Earnings Yield | 5.06% |
| PEGY Ratio | 0.0472 |
| Operating PE Ratio | 16.11 |
| Normalized PE Ratio | 18.17 |